vs

Side-by-side financial comparison of AMREP CORP. (AXR) and SurgePays, Inc. (SURG). Click either name above to swap in a different company.

SurgePays, Inc. is the larger business by last-quarter revenue ($16.2M vs $14.6M, roughly 1.1× AMREP CORP.). AMREP CORP. runs the higher net margin — 21.6% vs -85.6%, a 107.2% gap on every dollar of revenue. On growth, AMREP CORP. posted the faster year-over-year revenue change (93.8% vs 68.7%). Over the past eight quarters, AMREP CORP.'s revenue compounded faster (-13.6% CAGR vs -28.2%).

AMREP Corporation is a real estate and media services company based in Princeton, New Jersey, in the United States. It was founded in 1961 as The American Realty and Petroleum Corporation.

SurgePays, Inc. is a U.S.-headquartered fintech and telecommunications company focused on serving underbanked and low-income communities across the country. It offers prepaid wireless plans, reloadable debit cards, digital banking solutions, and daily consumer products through a nationwide network of independent local retail partners such as convenience stores.

AXR vs SURG — Head-to-Head

Bigger by revenue
SURG
SURG
1.1× larger
SURG
$16.2M
$14.6M
AXR
Growing faster (revenue YoY)
AXR
AXR
+25.1% gap
AXR
93.8%
68.7%
SURG
Higher net margin
AXR
AXR
107.2% more per $
AXR
21.6%
-85.6%
SURG
Faster 2-yr revenue CAGR
AXR
AXR
Annualised
AXR
-13.6%
-28.2%
SURG

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
AXR
AXR
SURG
SURG
Revenue
$14.6M
$16.2M
Net Profit
$3.1M
$-13.9M
Gross Margin
-14.8%
Operating Margin
20.6%
-79.1%
Net Margin
21.6%
-85.6%
Revenue YoY
93.8%
68.7%
Net Profit YoY
338.9%
30.0%
EPS (diluted)
$0.58
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXR
AXR
SURG
SURG
Q1 26
$14.6M
Q4 25
$9.4M
$16.2M
Q3 25
$17.9M
$18.7M
Q2 25
$11.2M
$11.5M
Q1 25
$7.5M
$10.6M
Q4 24
$11.9M
$9.6M
Q3 24
$19.1M
$4.8M
Q2 24
$19.5M
$15.1M
Net Profit
AXR
AXR
SURG
SURG
Q1 26
$3.1M
Q4 25
$1.2M
$-13.9M
Q3 25
$4.7M
$-7.5M
Q2 25
$3.9M
$-7.1M
Q1 25
$717.0K
$-7.6M
Q4 24
$4.0M
$-19.8M
Q3 24
$4.1M
$-14.3M
Q2 24
$4.1M
$-12.9M
Gross Margin
AXR
AXR
SURG
SURG
Q1 26
Q4 25
-14.8%
Q3 25
-13.9%
Q2 25
-23.0%
Q1 25
-27.8%
Q4 24
-117.0%
Q3 24
-164.2%
Q2 24
-22.8%
Operating Margin
AXR
AXR
SURG
SURG
Q1 26
20.6%
Q4 25
11.9%
-79.1%
Q3 25
34.4%
-37.2%
Q2 25
31.7%
-59.1%
Q1 25
5.7%
-71.7%
Q4 24
26.4%
-209.0%
Q3 24
26.1%
-299.4%
Q2 24
23.9%
-72.1%
Net Margin
AXR
AXR
SURG
SURG
Q1 26
21.6%
Q4 25
12.8%
-85.6%
Q3 25
26.3%
-40.1%
Q2 25
34.8%
-61.5%
Q1 25
9.5%
-72.2%
Q4 24
33.9%
-206.5%
Q3 24
21.3%
-299.3%
Q2 24
21.2%
-85.3%
EPS (diluted)
AXR
AXR
SURG
SURG
Q1 26
$0.58
Q4 25
$0.22
$-0.68
Q3 25
$0.87
$-0.38
Q2 25
$0.73
$-0.36
Q1 25
$0.13
$-0.38
Q4 24
$0.75
$-1.07
Q3 24
$0.76
$-0.73
Q2 24
$0.77
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXR
AXR
SURG
SURG
Cash + ST InvestmentsLiquidity on hand
$50.0M
$1.7M
Total DebtLower is stronger
$21.0K
$13.3M
Stockholders' EquityBook value
$139.4M
$-15.3M
Total Assets
$143.9M
$8.5M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXR
AXR
SURG
SURG
Q1 26
$50.0M
Q4 25
$44.6M
$1.7M
Q3 25
$48.9M
$2.5M
Q2 25
$39.5M
$4.4M
Q1 25
$36.9M
$5.4M
Q4 24
$40.1M
$11.8M
Q3 24
$40.4M
$23.7M
Q2 24
$29.7M
Total Debt
AXR
AXR
SURG
SURG
Q1 26
$21.0K
Q4 25
$23.0K
$13.3M
Q3 25
$25.0K
$12.0M
Q2 25
$26.0K
$9.6M
Q1 25
$29.0K
$3.6M
Q4 24
$32.0K
$4.0M
Q3 24
$34.0K
$4.4M
Q2 24
$35.0K
$4.8M
Stockholders' Equity
AXR
AXR
SURG
SURG
Q1 26
$139.4M
Q4 25
$136.0M
$-15.3M
Q3 25
$134.7M
$-6.4M
Q2 25
$130.0M
$116.1K
Q1 25
$126.0M
$7.8M
Q4 24
$125.1M
$15.3M
Q3 24
$122.2M
$33.2M
Q2 24
$118.0M
$46.2M
Total Assets
AXR
AXR
SURG
SURG
Q1 26
$143.9M
Q4 25
$140.1M
$8.5M
Q3 25
$140.7M
$14.5M
Q2 25
$133.8M
$15.2M
Q1 25
$128.9M
$15.7M
Q4 24
$129.1M
$24.0M
Q3 24
$127.0M
$41.5M
Q2 24
$122.8M
$56.4M
Debt / Equity
AXR
AXR
SURG
SURG
Q1 26
0.00×
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
82.67×
Q1 25
0.00×
0.46×
Q4 24
0.00×
0.26×
Q3 24
0.00×
0.13×
Q2 24
0.00×
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXR
AXR
SURG
SURG
Operating Cash FlowLast quarter
$5.4M
$-3.6M
Free Cash FlowOCF − Capex
$5.4M
FCF MarginFCF / Revenue
37.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.72×
TTM Free Cash FlowTrailing 4 quarters
$20.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXR
AXR
SURG
SURG
Q1 26
$5.4M
Q4 25
$-4.3M
$-3.6M
Q3 25
$9.5M
$-4.6M
Q2 25
$10.2M
$-6.1M
Q1 25
$-3.2M
$-7.0M
Q4 24
$-182.0K
$-7.9M
Q3 24
$10.7M
$-13.3M
Q2 24
$10.7M
$-4.1M
Free Cash Flow
AXR
AXR
SURG
SURG
Q1 26
$5.4M
Q4 25
$-4.3M
Q3 25
$9.5M
Q2 25
$9.7M
Q1 25
$-3.3M
Q4 24
$-268.0K
Q3 24
$10.7M
Q2 24
$10.3M
FCF Margin
AXR
AXR
SURG
SURG
Q1 26
37.0%
Q4 25
-45.9%
Q3 25
53.2%
Q2 25
86.4%
Q1 25
-43.4%
Q4 24
-2.3%
Q3 24
55.8%
Q2 24
52.5%
Capex Intensity
AXR
AXR
SURG
SURG
Q1 26
0.1%
Q4 25
0.6%
Q3 25
0.1%
Q2 25
5.2%
Q1 25
0.3%
Q4 24
0.7%
Q3 24
0.2%
Q2 24
2.3%
Cash Conversion
AXR
AXR
SURG
SURG
Q1 26
1.72×
Q4 25
-3.54×
Q3 25
2.03×
Q2 25
2.63×
Q1 25
-4.51×
Q4 24
-0.05×
Q3 24
2.63×
Q2 24
2.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons